{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:42:52Z","timestamp":1791513772954,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.neuropharm.2023.109603","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T20:36:23Z","timestamp":1684960583000},"page":"109603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["GLP-1R knockdown abrogates the protective effects of liraglutide on ischaemic stroke via inhibition of M2 polarisation and activation of NLRP3 inflammasome by reducing Nrf2 activation"],"prefix":"10.1016","volume":"237","author":[{"given":"Xian-kun","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-hang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-sheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109603_bib1","series-title":"NLRP3 Inflammasome in Ischemic Stroke: as Possible Therapeutic Target","first-page":"574","volume":"vol. 14","author":"Alishahi","year":"2019"},{"key":"10.1016\/j.neuropharm.2023.109603_bib2","series-title":"Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues-Liraglutide and Semaglutide","first-page":"661","volume":"vol. 33","author":"Basalay","year":"2019"},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109603_bib3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.STR.17.3.472","article-title":"Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination","volume":"17","author":"Bederson","year":"1986","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109603_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12974-017-0963-x","article-title":"Homocysteine exaggerates microglia activation and neuroinflammation through microglia localized STAT3 overactivation following ischemic stroke","volume":"14","author":"Chen","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2023.109603_bib5","first-page":"1","article-title":"Liraglutide activates the Nrf2\/HO-1 antioxidant pathway and protects brain nerve cells against cerebral ischemia in diabetic rats","volume":"2018","author":"Deng","year":"2018","journal-title":"Comput. Intell. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109603_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3094504","article-title":"Liraglutide activates the Nrf2\/HO-1 antioxidant pathway and protects brain nerve cells against cerebral ischemia in diabetic rats","volume":"2018","author":"Deng","year":"2018","journal-title":"Comput. Intell. Neurosci."},{"issue":"15","key":"10.1016\/j.neuropharm.2023.109603_bib7","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jacc.2019.12.072","article-title":"Primary and secondary prevention of ischemic stroke and cerebral hemorrhage: JACC focus seminar","volume":"75","author":"Diener","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.neuropharm.2023.109603_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2017.01.045","article-title":"Delayed administration of the GLP-1 receptor agonist liraglutide improves metabolic and functional recovery after cerebral ischemia in rats","volume":"641","author":"Dong","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109603_bib9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/glia.23738","article-title":"Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS\/NF-\u03baB-dependent signaling and glucose consumption","volume":"68","author":"Dos-Santos-Pereira","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2023.109603_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8825954","article-title":"Inhibited CSF1R alleviates ischemia injury via inhibition of microglia M1 polarization and NLRP3 pathway","volume":"2020","author":"Du","year":"2020","journal-title":"Neural Plast."},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109603_bib11","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1007\/s12035-022-03197-4","article-title":"Therapeutic potentials of MicroRNA-126 in cerebral ischemia","volume":"60","author":"Ebrahimi","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2023.109603_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fncel.2020.00155","article-title":"Inhibition of NLRP3 inflammasome: a prospective target for the treatment of ischemic stroke","volume":"14","author":"Feng","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109603_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12031-015-0696-1","article-title":"Glucagon-like peptide-1 strengthens the barrier integrity in primary cultures of rat brain endothelial cells under basal and hyperglycemia conditions","volume":"59","author":"Fukuda","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109603_bib14","series-title":"Protective Role of Nrf2 against Ischemia Reperfusion Injury and Cardiac Allograft Vasculopathy","first-page":"1262","volume":"vol. 20","author":"Fukunaga","year":"2020"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109603_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000450648","article-title":"Alpha-tocopherol reduces brain edema and protects blood-brain barrier integrity following focal cerebral ischemia in rats","volume":"26","author":"Haghnejad Azar","year":"2017","journal-title":"Med. Princ. Pract."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109603_bib16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/FJC.0000000000000945","article-title":"Vinpocetine attenuates ischemic stroke through inhibiting NLRP3 inflammasome expression in mice","volume":"77","author":"Han","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109603_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/imr.12285","article-title":"NLRP3 at the interface of metabolism and inflammation","volume":"265","author":"Haneklaus","year":"2015","journal-title":"Immunol. Rev."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2023.109603_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000441627","article-title":"Malignant MCA infarction: pathophysiology and imaging for early diagnosis and management decisions","volume":"41","author":"Heiss","year":"2016","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.neuropharm.2023.109603_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jneuroim.2017.04.007","article-title":"Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology","volume":"309","author":"Hendrickx","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109603_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12974-019-1498-0","article-title":"NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes","volume":"16","author":"Hong","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109603_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2202-13-33","article-title":"Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis","volume":"13","author":"Hunter","year":"2012","journal-title":"BMC Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109603_bib22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4049\/jimmunol.181.1.680","article-title":"The transcription factor Nrf2 is a therapeutic target against brain inflammation","volume":"181","author":"Innamorato","year":"2008","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.neuropharm.2023.109603_bib23","first-page":"2006","article-title":"Modulators of microglia activation and polarization in ischemic stroke (Review)","volume":"21","author":"Jiang","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109603_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5607\/en.2017.26.4.227","article-title":"Anti-inflammatory effect of glucagon like peptide-1 receptor agonist, exendin-4, through modulation of IB1\/JIP1 expression and JNK signaling in stroke","volume":"26","author":"Kim","year":"2017","journal-title":"Exp Neurobiol"},{"key":"10.1016\/j.neuropharm.2023.109603_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.taap.2016.12.005","article-title":"EX4 stabilizes and activates Nrf2 via PKC\u03b4, contributing to the prevention of oxidative stress-induced pancreatic beta cell damage","volume":"315","author":"Kim","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109603_bib26","series-title":"Analysis of the Neuroprotective Effect of GLP-1 Receptor Agonist Peptide on Cerebral Ischemia-Reperfusion Injury by Quantitative Proteomics Mass Spectrometry","volume":"vol. 11","author":"Li","year":"2021"},{"key":"10.1016\/j.neuropharm.2023.109603_bib27","series-title":"Naringenin Protects against Acute Pancreatitis in Two Experimental Models in Mice by NLRP3 and Nrf2\/HO-1 Pathways","author":"Li","year":"2018"},{"issue":"21","key":"10.1016\/j.neuropharm.2023.109603_bib28","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.1989","article-title":"Protocol for primary microglial culture preparation","volume":"6","author":"Lian","year":"2016","journal-title":"Bio Protoc"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109603_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/oby.22666","article-title":"Liraglutide lowers body weight set point in DIO rats and its relationship with hypothalamic microglia activation","volume":"28","author":"Liao","year":"2020","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109603_bib30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/oby.22666","article-title":"Liraglutide lowers body weight set point in DIO rats and its relationship with hypothalamic microglia activation","volume":"28","author":"Liao","year":"2020","journal-title":"Obesity"},{"key":"10.1016\/j.neuropharm.2023.109603_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fnagi.2017.00233","article-title":"Curcumin protects against ischemic stroke by titrating microglia\/macrophage polarization","volume":"9","author":"Liu","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109603_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fnagi.2017.00233","article-title":"Curcumin protects against ischemic stroke by titrating microglia\/macrophage polarization","volume":"9","author":"Liu","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"14","key":"10.1016\/j.neuropharm.2023.109603_bib33","first-page":"4818","article-title":"Liraglutide improves pancreatic islet \u03b2 cell apoptosis in rats with type 2 diabetes mellitus by inhibiting the IKK\u03b5\/NF-\u03baB pathway","volume":"25","author":"Liu","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109603_bib34","first-page":"1","article-title":"GLP-1 receptor agonists in diabetes for stroke prevention: a systematic review and meta-analysis","author":"Malhotra","year":"2020","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.neuropharm.2023.109603_bib35","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1007\/s11064-016-1944-7","article-title":"Protective effect of aliskiren in experimental ischemic stroke: up-regulated p-PI3K, p-AKT, bcl-2 expression, attenuated bax expression","volume":"41","author":"Miao","year":"2016","journal-title":"Neurochem. Res."},{"issue":"8","key":"10.1016\/j.neuropharm.2023.109603_bib36","article-title":"Population pharmacokinetics of liraglutide, a once-daily human glucagon-like peptide-1 analog, in healthy volunteers and subjects with type 2 diabetes, and comparison to twice-daily exenatide","volume":"50","author":"Mphil","year":"2010","journal-title":"John Wiley & Sons, Ltd."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109603_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00395-021-00873-9","article-title":"Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke","volume":"116","author":"Nizari","year":"2021","journal-title":"Basic Res. Cardiol."},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109603_bib38","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2337\/db08-1193","article-title":"GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice","volume":"58","author":"Noyan-Ashraf","year":"2009","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.neuropharm.2023.109603_bib39","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.7150\/ijbs.68974","article-title":"Activation of glucagon-like peptide-1 receptor in microglia attenuates neuroinflammation-induced glial scarring via rescuing Arf and Rho GAP adapter protein 3 expressions after nerve injury","volume":"18","author":"Qian","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109603_bib40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neuropharm.2013.11.004","article-title":"NRF2-regulation in brain health and disease: implication of cerebral inflammation","volume":"79","author":"Sandberg","year":"2014","journal-title":"Neuropharmacology"},{"issue":"1\u20133","key":"10.1016\/j.neuropharm.2023.109603_bib41","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.regpep.2011.11.008","article-title":"GLP-1 analogue, Liraglutide protects human umbilical vein endothelial cells against high glucose induced endoplasmic reticulum stress","volume":"174","author":"Schisano","year":"2012","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2023.109603_bib42","first-page":"4723","article-title":"Electroacupuncture alleviates ischemic brain injury by inhibiting the miR-223\/NLRP3 pathway","volume":"25","author":"Sha","year":"2019","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109603_bib43","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12974-019-1638-6","article-title":"The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke","volume":"16","author":"Shan","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109603_bib44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10753-020-01344-4","article-title":"GLP-1R agonist liraglutide attenuates inflammatory reaction and neuronal apoptosis and reduces early brain injury after subarachnoid hemorrhage in rats","volume":"44","author":"Tu","year":"2021","journal-title":"Inflammation"},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109603_bib45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/ars.2017.7003","article-title":"A dual AMPK\/Nrf2 activator reduces brain inflammation after stroke by enhancing microglia M2 polarization","volume":"28","author":"Wang","year":"2018","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.neuropharm.2023.109603_bib46","series-title":"Liraglutide and its Neuroprotective Properties-Focus on Possible Biochemical Mechanisms in Alzheimer's Disease and Cerebral Ischemic Events","volume":"vol. 20","author":"Wici\u0144ski","year":"2019"},{"issue":"5","key":"10.1016\/j.neuropharm.2023.109603_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051050","article-title":"Liraglutide and its neuroprotective properties-focus on possible biochemical mechanisms in alzheimer's disease and cerebral ischemic events","volume":"20","author":"Wici\u0144ski","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109603_bib48","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuropharm.2017.09.040","article-title":"Exendin-4 attenuates neuronal death via GLP-1R\/PI3K\/Akt pathway in early brain injury after subarachnoid hemorrhage in rats","volume":"128","author":"Xie","year":"2018","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109603_bib49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00011-017-1095-6","article-title":"Nrf2\/ARE pathway inhibits ROS-induced NLRP3 inflammasome activation in BV2 cells after cerebral ischemia reperfusion","volume":"67","author":"Xu","year":"2018","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.neuropharm.2023.109603_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113142","article-title":"Ischemic preconditioning provides long-lasting neuroprotection against ischemic stroke: the role of Nrf2","volume":"325","author":"Yang","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109603_bib51","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8260111","article-title":"Therapeutic potential of liraglutide for diabetes-periodontitis comorbidity: killing two birds with one stone","volume":"2022","author":"Yang","year":"2022","journal-title":"J. Diabetes Res."},{"issue":"7","key":"10.1016\/j.neuropharm.2023.109603_bib52","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1007\/s11064-022-03574-4","article-title":"Liraglutide ameliorates cerebral ischemia in mice via antipyroptotic pathways","volume":"47","author":"Yang","year":"2022","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2023.109603_bib53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.intimp.2017.01.034","article-title":"Sulforaphane improves outcomes and slows cerebral ischemic\/reperfusion injury via inhibition of NLRP3 inflammasome activation in rats","volume":"45","author":"Yu","year":"2017","journal-title":"Int. Immunopharm."},{"issue":"1","key":"10.1016\/j.neuropharm.2023.109603_bib54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12974-016-0541-7","article-title":"Oxytocin inhibits lipopolysaccharide-induced inflammation in microglial cells and attenuates microglial activation in lipopolysaccharide-treated mice","volume":"13","author":"Yuan","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109603_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148827","article-title":"An orally active allosteric GLP-1 receptor agonist is neuroprotective in cellular and rodent models of stroke","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neuropharm.2023.109603_bib56","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.bbrc.2017.09.151","article-title":"Polydatin ameliorates diabetic cardiomyopathy via Sirt3 activation","volume":"493","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2023.109603_bib57","series-title":"Nrf2\u207bARE Signaling Acts as Master Pathway for the Cellular Antioxidant Activity of Fisetin","volume":"vol. 24","author":"Zhang","year":"2019"},{"key":"10.1016\/j.neuropharm.2023.109603_bib58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.brainresbull.2020.11.008","article-title":"Exendin-4 induces a novel extended effect of ischemic tolerance via crosstalk with IGF-1R","volume":"169","author":"Zhang","year":"2021","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.neuropharm.2023.109603_bib59","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.5070","article-title":"Neuronal injuries in cerebral infarction and ischemic stroke: from mechanisms to treatment (Review)","volume":"49","author":"Zhao","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuropharm.2023.109603_bib60","article-title":"The neuroprotection of liraglutide against ischaemia-induced apoptosis through the activation of the PI3K\/AKT and MAPK pathways","volume":"6","author":"Zhu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2023.109603_bib61","article-title":"The neuroprotection of liraglutide against ischaemia-induced apoptosis through the activation of the PI3K\/AKT and MAPK pathways","volume":"6","author":"Zhu","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823001934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823001934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:24:46Z","timestamp":1758439486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823001934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":61,"alternative-id":["S0028390823001934"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109603","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1R knockdown abrogates the protective effects of liraglutide on ischaemic stroke via inhibition of M2 polarisation and activation of NLRP3 inflammasome by reducing Nrf2 activation","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109603"}}